predictions?, page-19

I'm not too familiar with Ceniciviroc, however Ocaliva gained FDA warnings after being found it related to 19 patient deaths. This may not be the path to pursue a joint venture.

Which raises another question does Ocaliva still have its "breakthrough therapy status" from the FDA? Regardless, we could only dream of the $1.5B market cap. that Intercept trades on.

I'll do more research on Ceniciviroc, when time permits.